Drugs / alpha-tocopherolquinone
alpha-tocopherolquinone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01035671 | Dec 2009 → Feb 2011 | Friedreich ataxia | Penwest Pharmaceuticals Co. | Completed | Missed primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | alpha-tocopherolquinone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01035671 ↗ |
| Known as | A0001 | “alpha-tocopherolquinone (A0001)” NCT01035671 ↗ |
| Known as | EPI-A0001 | “A0001 (α-tocopheryl quinone; EPI-A0001)” PMID 22744651 ↗ Jun 2012 |
| Known as | α-tocopheryl quinone | “A0001 (α-tocopheryl quinone; EPI-A0001)” PMID 22744651 ↗ Jun 2012 |
| Route | Oral | “oral A0001 capsules” NCT01035671 ↗ |